Inokuchi J, Jimbo M, Momosaki K, Shimeno H, Nagamatsu A, Radin N S
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Fukuoka University, Japan.
Cancer Res. 1990 Oct 15;50(20):6731-7.
In view of the increasing evidence that glucosphingolipids (GSLs) on tumor cell surfaces play an important role in tumor metastasis, an inhibitor of glucosylceramide synthase, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP) was used to evaluate the role of GSLs in this respect. Treatment of Lewis lung carcinoma cells with 5 microM D-PDMP resulted in a time-dependent marked decrease in levels of all cellular GSLs (glucosylceramide, lactosylceramide, ceramide trihexoside, globoside, and ganglioside GM3). By 6 days, the total GSL content was reduced to approximately 20% of the level in the untreated control cells and at the same time the lung-colonizing capacity of the PDMP-treated cells in inoculated mice was greatly reduced. Closely associated with the degree of GSL depletion, the ability of the cells to invade reconstituted basement membranes in vitro was also reduced, suggesting that GSLs in tumor cell membranes modulate the cell surface interaction with basement membrane components. In order to assess a possible contribution of the defective capacities to drug-induced suppression of experimental metastasis and invasion, we tested the effect of D-PDMP on attachment and migration to laminin and fibronectin and found that the inhibitor specifically reduced the laminin-mediated attachment and migration, whereas it had no effect on fibronectin-mediated attachment and migration. These effects of the inhibitor on lung colonizing capacity in vivo and the invasion, adhesion, and migration properties of the cells in vitro were reversible within 24 h after removal of the drug. By contrast, L-PDMP (the enantiomeric form of D-PDMP), which has no inhibitory activity on glucosylceramide synthesis, did not cause any of the changes produced by D-PDMP. Together, these results suggest that GSLs in tumor cell membranes are essential for the metastatic spread of tumor cells through basement membranes, modulating the interaction of laminin and its receptors.
鉴于越来越多的证据表明肿瘤细胞表面的糖鞘脂(GSLs)在肿瘤转移中起重要作用,我们使用了一种葡萄糖神经酰胺合酶抑制剂D-苏式-1-苯基-2-癸酰氨基-3-吗啉代-1-丙醇(D-PDMP)来评估GSLs在这方面的作用。用5微摩尔/升的D-PDMP处理Lewis肺癌细胞,导致所有细胞GSLs(葡萄糖神经酰胺、乳糖神经酰胺、神经酰胺三己糖苷、红细胞糖苷脂和神经节苷脂GM3)水平随时间显著下降。到第6天,总GSL含量降至未处理对照细胞水平的约20%,同时接种小鼠中经PDMP处理的细胞的肺定植能力大大降低。与GSL消耗程度密切相关的是,细胞在体外侵袭重组基底膜的能力也降低了,这表明肿瘤细胞膜中的GSLs调节细胞表面与基底膜成分的相互作用。为了评估这些缺陷能力对药物诱导的实验性转移和侵袭抑制的可能贡献,我们测试了D-PDMP对细胞黏附于层粘连蛋白和纤连蛋白以及迁移的影响,发现该抑制剂特异性降低了层粘连蛋白介导的黏附和迁移,而对纤连蛋白介导的黏附和迁移没有影响。该抑制剂对体内肺定植能力以及细胞体外侵袭、黏附和迁移特性的这些影响在去除药物后24小时内是可逆的。相比之下,对葡萄糖神经酰胺合成没有抑制活性的L-PDMP(D-PDMP的对映体形式)没有引起D-PDMP所产生的任何变化。总之,这些结果表明肿瘤细胞膜中的GSLs对于肿瘤细胞通过基底膜的转移扩散至关重要,调节层粘连蛋白及其受体的相互作用。